Uromigos-Testis Cancer

The UromigosThe Uromigos | August 1, 2023
Christian Kollmannsberger, MD, FRCPC, discusses his presentation on utilizing miR371 as a biomarker for germ cell tumors.
Listen Now
The UromigosThe Uromigos | November 11, 2022
Darren Feldman describes different approaches to relapsed germ cell tumors and the TIGER study.
The UromigosThe Uromigos | April 14, 2021
Silke Gillessen discusses the back-to-back JCO papers on risk classification for germ cell cancer.
The UromigosThe Uromigos | September 13, 2022
Christian Kollmannsberger gets into the Christmas spirit by discussing highlights of 2020 in the world of testis cancer.
The UromigosThe Uromigos | September 13, 2022
Dr. Jan Oldenburg discusses stage 1 testis cancer treatment choices, the dilemma of high-dose therapy for relapse, and more.
Advertisement
Advertisement